A phase II study of docetaxel (Taxotere), estramustine, and low-dose hydrocortisone in men with hormone-refractory prostate cancer: preliminary results of cancer and leukemia group B Trial 9780.
A phase II study of docetaxel (Taxotere), estramustine, and low-dose hydrocortisone in men with hormone-refractory prostate cancer: preliminary results of cancer and leukemia group B Trial 9780.
复制标题
多西他赛（泰索帝）、雌莫司汀和低剂量氢化可的松治疗激素难治性前列腺癌男性的 II 期研究：癌症和白血病 B 组试验 9780 的初步结果。
作者：
Savarese,D;Taplin,ME;Halabi,S;Hars,V;Kreis,W;Vogelzang,N
